What is it about?
The protein binding ratio of LVFX has little clinical relevance, and it is not necessary to monitor it for LVFX therapy in HD patients.
Featured Image
Read the Original
This page is a summary of: No effect of protein binding ratio of levofloxacin in hemodialysis patients, Renal Replacement Therapy, July 2016, Springer Science + Business Media,
DOI: 10.1186/s41100-016-0042-2.
You can read the full text:
Contributors
The following have contributed to this page
